Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Boost Publication Collaboration Virtually – Engaging Your Advisors Creatively

March 20, 2025 | Advisory Boards, DOL engagement, HCP collaboration, HCP engagement, Impetus Digital, KOL Engagement, Online advisory boards, Pharma advisory, Pharma engagement, Publication Planning, Publication co-creation, Virtual advisory boards, Virtual collaboration, consesus document, digital publication planning, life science advisory board, medical affairs, scientific advisory meeting, virtual scientific exchange 

Tired of traditional advisory board limitations? Explore innovative ways to engage your KOLs, HCPs, and MSLs in our new series! Learn how to co-create impactful publications virtually in our first tip of this top 10 tips series.

Discover how to revolutionize publication planning, development, and collaboration in the digital age. Empower your KOLs, DOLs, MSLs, HCPs, and other geographically dispersed stakeholders to co-create impactful publications, including peer-reviewed articles, guidelines, and educational materials. Learn how asynchronous and synchronous tools streamline every step of the process, from idea conception to final dissemination, resulting in faster results and higher engagement rates compared to traditional in-person meetings.

  1. Learn how to leverage digital solutions to enhance collaboration on publications, including:
  • Co-creating peer-reviewed articles and guidelines
  • Streamlining literature reviews and draft development
  • Utilizing asynchronous and synchronous tools for efficient communication
  • Increasing engagement with geographically dispersed advisors

Explore how the Impetus InSite Platform® can transform your publication process.

For more creative ways to engage your advisors, visit: https://www.impetusdigital.com/2019/11/15/top-10-creative-ways-to-engage-your-advisors/

Learn more about Impetus Digital’s solutions: www.impetusdigital.com

Schedule a consultation: https://meetwithimpetus.com/

Stay connected:

#VirtualCollaboration #PublicationPlanning #AdvisoryBoards #DigitalEngagement #LifeSciences #Pharma #ImpetusDigital

This content was provided by Impetus Digital

Company Details

- PMLiVE

Impetus Digital

Email
Website

 Latest Content from  Impetus Digital 

Mastering Asynchronous Meetings: Open-Ended Questions – Impetus Digital Tip 1

Unlock the potential of asynchronous virtual meetings with the first tip from our "Top 10 Tips for Optimizing Asynchronous Virtual Meetings".

In-person, hybrid, or digital? State of Pharma meetings and events in 2024

We’re diving into the state of pharmaceutical meetings and events in 2024 and–once and for all–put the idea of in-person meetings being superior to rest.

Navigating Regulatory Challenges – Top 10 Most Important Advisor Questions

This quick video covers #9 of our Top 10 Most Important Advisor Questions, shedding light on the complexities of local and national regulatory issues in the Pharma and Life Sciences...

Top-5 Trends in Virtual KOL Engagement

Register now for one of our upcoming webinars (February 26-28)

Engaging with Different Perspectives – Top 10 Most Important Advisor Questions

In this quick clip, we highlight a vital tip from our 'Top 10 Most Important Advisor Questions' – essential for enhancing your virtual collaboration strategies in Pharma and Life Sciences....

Patient Advocate Engagement: A Customer Story

Learn how our client executed a series of 3 virtual touchpoints with 5 rare disease patient advocates to:- Develop a better understanding of the current treatment landscape and lived patient...

Tailored Marketing Strategies for Pharma – Top 10 Most Important Advisor Questions

In this video, we explore another crucial aspect of advisor questions when developing your virtual advisory board touchpoints – a key component for success in today's diverse healthcare landscape. 7....

Trends in Virtual Collaboration

Join us for a look at the top-5 emerging virtual collaboration trends...

Advisor Questions on Potential Data or Knowledge Gaps

As part of our top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board touchpoints, here's another one to keep in...

On a journey to diverse, inclusive, and more efficient rare disease trials

Although orphan drugs represent a sizeable portion of new drug approvals, most rare diseases still lack effective treatment. Even more so than for other conditions, rare disease management contains large care...